Publication Name	World Journal of Nephrology
Manuscript ID	101515
Country	India

Received	2024-09-17 12:03
Peer-Review Started	2024-09-17 12:04
To Make the First Decision
Return for Revision	2024-09-26 10:16
Revised	2024-10-21 09:59
Second Decision	2024-12-03 03:04
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-12-03 09:40
Articles in Press	2024-12-03 09:40
Publication Fee Transferred	2024-10-28 06:23
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-12-20 06:43
Publish the Manuscript Online	2025-01-20 08:27

ISSN	2220-6124 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Urology & Nephrology
Manuscript Type	Minireviews
Article Title	Optimizing chronic kidney disease management: The potential of a multi-strain probiotic formulation
Manuscript Source	Unsolicited Manuscript
All Author List	Deodatta Chafekar
ORCID	Author(s) ORCID Number Deodatta Chafekar http://orcid.org/0009-0001-6922-362X
Funding Agency and Grant Number
Corresponding Author	Deodatta Chafekar, MD, Professor, Dr V N Pawar Medical College, Director Supreme Kidney Care, OM Chambers, Opp. Holaram Colony, Sharanpur, Nashik 422005, Mahārāshtra, India. nchafy@hotmail.com
Key Words	Chronic kidney disease; Gut microbiota; Prebiotics; Lactobacillus; Bifidobacterium
Core Tip	Chronic kidney disease (CKD) is a major global health challenge marked by a gradual decline in kidney function and associated complications. Recent studies have suggested that dysbiosis of the gut microbiota plays a significant role in CKD progression to end-stage renal disease. Probiotics and prebiotics, particularly strains such as Lactobacillus and Bifidobacterium and combinations including Streptococcus thermophilus and Bacillus coagulans, show promise in managing CKD by restoring the gut microbiota balance. Although these findings are promising, further research is essential to comprehensively understand the impact of specific probiotic formulations on CKD outcomes and their potential as therapeutic interventions.
Publish Date	2025-01-20 08:27
Citation	<p>Chafekar D. Optimizing chronic kidney disease management: The potential of a multi-strain probiotic formulation. <i>World J Nephrol</i> 2025; 14(1): 101515</p>
URL	https://www.wjgnet.com/2220-6124/full/v14/i1/101515.htm
DOI	https://dx.doi.org/10.5527/wjn.v14.i1.101515

Full Article (PDF)	WJN-14-101515-with-cover.pdf
Manuscript File	101515_Auto_Edited_021149.docx
Answering Reviewers	101515-answering-reviewers.pdf
Audio Core Tip	101515-audio.mp4
Conflict-of-Interest Disclosure Form	101515-conflict-of-interest-statement.pdf
Copyright License Agreement	101515-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	101515-non-native-speakers.pdf
Peer-review Report	101515-peer-reviews.pdf
Scientific Misconduct Check	101515-scientific-misconduct-check.png
Scientific Editor Work List	101515-scientific-editor-work-list.pdf
CrossCheck Report	101515-crosscheck-report.pdf